BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
SNCA
,
Metabolism of xenobiotics
,
Hepatitis
,
Breast
,
Alcohol
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BRCA1 proteins
Summary
General Info
Curated Studies
Most Correlated Studies
Mammary tumors from 8 different mouse models of human breast cancer
Mammary tumors from multiple genetic mouse breast cancer models
Embryonic stem cell differentiation timecourse analysis via LIF withdrawal
MCF7 breast cancer cells with BRCA1 siRNA knockdown, polysomal and total RNA
Mammary gland MCF10A cells expressing BRCA1 and PALB2 shRNAs
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B-med…
BRCA1 the Versatile Defender: Molecular to Environmental Perspectives.
BRCA1: An Endocrine and Metabolic Regulator.
BRCA1 mislocalization leads to aberrant DNA damage response in heterozygous ABRAXAS1 mutation carrie…
BRCA1 as target for breast cancer prevention and therapy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Correlate BRCA1 Protein Expression With Response to DNA Damaging Chemotherapy
The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA…
Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer
Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fa…
Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metasta…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ